Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 36
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
under 65
WCCC-CO-7711R
NCI-D80-048-183
Last Modified:
7/5/2006
2.
Phase II/III Randomized Study of TMX/FXM vs TMX/Danazol for Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
no age specified
NCI
NCI-81-C-72
NCI-MB-153, NCI-T83-1460N, T83-1460
3.
Phase II/III Therapy with TMX vs TMX/FXM for Locally Inoperable, Recurrent, or Metastatic Carcinoma of the Breast
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
NCI
NCCTG-813251
MAYO-813251, NCCTG-81-32-51
Last Modified:
11/1/1988
4.
Phase II/III Multimodality Therapy with Surgery, CTX/ADR/5-FU/TMX/FLU, plus Radiotherapy for Stage III Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
18 to 69
WCCC-CO-8111
NCI-D81-048-515
Last Modified:
4/26/2007
5.
Phase III Chemohormonal Therapy with ADR/CCNU/VCR/FXM vs CTX/MPA plus Immunotherapy with C. parvum for Metastatic Renal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
20 to 70
MSHMC-REN-2
6.
Phase III Chemotherapy with Fluoxymesterone, Oxymetholone, Testosterone and Splenectomy for Myeloproliferative Disorders and Refractory Anemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Completed
no age specified
PVSG-2
7.
Phase III Hormonal Therapy with Calusterone vs Fluoxymesterone for Progressive Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
CBCG-4280
UICC-72059
8.
Phase III Hormone Therapy with FXM Plus Calcium Carbonate/Vitamin D and Calcitonin for Recurrent Breast Carcinoma with Osseous Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
postmenopausal
CBCG-4400
Last Modified:
8/10/2007
9.
Phase III Study of Two CMFVP (CTX/MTX/5-FU/VCR/PRED) Regimens with or without VATH (VBL/ADR/Thiotepa/FXM) as Adjuvant Chemotherapy for Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
75 and under
NCI
CLB-8082
CALGB-8082
Last Modified:
8/10/2007
10.
Phase III CAF (CTX/ADR/5-FU) vs VATH (VBL/ADR/Thiotepa/HAL) vs Alternating VATH and CMFVP (CTX/MTX/5-FU/VCR/PRED) for Stage III/IV or Recurrent Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
16 to 70
NCI
CLB-8281
CALGB-8281
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute